Sex Differences in E-cig Perception: Study 1

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Oct 2, 2026
    • Primary endpoints revised (3)
    • Eligibility criteria expanded, about 12 words
  2. Minor Re-verified, no change to tracked fieldsv9
  3. Minor Trial status: Recruiting to Completed
    • Enrollment target: estimated 60 to confirmed 66
    • Primary and study completion dates changed from estimate of Jul 30, 2025 to Jul 18, 2025
    • Site details revised
    v8
  4. Minor Primary and study completion dates: Jul 2025 to Jul 30, 2025v7
  5. Minor Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2024 to Apr 30, 2024
    v5
  2. Notable Primary and study completion dates: Jul 2024 to Jul 2025
    • Start date: Jan 2024 to Apr 2024
    v4
  3. Notable Start date: Oct 2023 to Jan 2024v3
  4. Notable Start date: Dec 2022 to Oct 2023
    • Collaborators expanded, about 6 words
    v2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
490 trials monitored
See 31 trials at risk
The primary objective is to examine the influence of sex on sensory effects, appeal, and reinforcing value of nicotine containing e-cigs in popular flavor components; sweet and cooling.
Trial Details
NCT Number NCT05432830
Lead Sponsor Yale University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)
Nicotine Addiction, E-Cig Use, Cigarette Smoking, Sex Differences
Related terms Cigarette Smoking, Tobacco Use Disorder, Vaping
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov